SGInnovate
VC Fund
Singapore, Singapore
SGInnovate is a VC fund in Singapore focused on Artificial Intelligence and Software. At SGInnovate, our mission is to help entrepreneurial scientists build Deep Tech startups. The world has hard problems to solve, and hard-tech answers are needed. We help entrepreneurs who want to solve hard problems build companies. We believe Singapore has the resources and capabilities to tackle hard problems that matter to people around theworld. SGInnovate has been established to help ambitious and capable people to build 'technology-intensive' products borne out of science research. Our commitment is to use the full power of the Singapore ecosystem to achieve this mission.
- Total investments:
- 107
- Last investment:
- Lead investor:
- 24%
Last updated:
For AI agents: llms.txt
Industries SGInnovate invests in
Stages SGInnovate invests in
Countries SGInnovate invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $612k–$5M
- Series A
- $2M–$18M
Investment Focus
Industry
- Artificial Intelligence 29 (27%)
- Software 22 (21%)
- Information Technology 22 (21%)
- Machine Learning 16 (15%)
- Health Care 12 (11%)
Stage
- Seed 52 (49%)
- Series A 20 (19%)
- Convertible Note 9 (8%)
- Series B 8 (7%)
- Pre-Seed 4 (4%)
Country
- Singapore 65 (61%)
- United States 11 (10%)
- Canada 2 (2%)
- Israel 1 (1%)
- Ireland 1 (1%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Hsien Hui Tong
Executive Director - Investments
|
Executive Director - Investments | Total investments: 8 | Find email | |
Jui Lim
Chief Executive Officer
|
Chief Executive Officer | Total investments: 2 | Find email | |
Pang Heng Soon
Chief Operating Officer
|
Chief Operating Officer | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| N&E Innovations is a med-tech company that develops antimicrobial products. | $1.7M / Series A / Sep 09, 2026 | ||
| PQCee is a cybersecurity and quantum technology company that develops post-quantum cryptography (PQC) solutions to help organizations secure digital systems against future quantum computing threats. It designs software products and security infrastructure that enable enterprises to transition to quantum-resistant encryption, digital signatures, andkey management while maintaining compatibility with existing IT environments.The company's product portfolio includes SafeQuard, a post-quantum end-to-end encryption solution for web applications; QKDLite, a quantum-safe key management platform that integrates with hardware security modules (HSMs) and quantum key distribution (QKD) networks; inoQulate, a post-quantum public key infrastructure (PKI) platform for quantum-safe certificates, email, PDF signing, and TLS; AStablish for digital asset assurance; and QuICScript, a browser-based quantum computing simulator. These solutions help organizations protect sensitive communications, digital identities, and cryptographic infrastructure against "harvest now, decrypt later" attacks. | $3.9M / Seed / Jul 17, 2026 | ||
| H3 Zoom is an AI-powered inspection intelligence platform focused on the built environment, helping organizations assess and manage buildings and critical infrastructure. It processes visual and sensor data from drones, 360° cameras, robotics, and other capture tools to generate structured inspection insights. The platform uses AI to detect,classify, and localize defects while assigning severity levels based on engineering and regulatory standards. It produces audit-ready reports and remediation recommendations designed to support maintenance planning and compliance workflows. | $3.6M / Series A / Jun 22, 2026 | ||
| Clearbot creates autonomous and electric boats that augments different marine services. | $1.8M / Seed / Jun 08, 2026 | ||
| Brano Therapeutics is a biotech developing therapies for cardio-metabolic and heart failure diseases. | $6.8M / Seed / May 06, 2026 | ||
| Botsync builds autonomous mobile robots to automate and digitize movement of goods from point to point for the logistics and manufacturing industry. Our robots can carry payloads from 500 kg to 1 tonne and are designed to operate in dynamic environments. Botsync's AMRs can be implemented at new facilities in minimal time with very minimalchanges to the existing infrastructure. With our technology, we hope to pioneer and push for larger scale adoptions of robotic automation in Asia's logistics and manufacturing industry. | Series A / Jan 14, 2026 | ||
| Vycarb is a Brooklyn-based firm that enables decentralized carbon removal through real-time, autonomous, and direct detection of CO2 in water. | $5M / Seed / Oct 06, 2025 | ||
| Greenitio is transforming the industry with its AI-driven platform technology to produce functional biopolymers from abundant natural resources as a sustainable alternative to petrochemical polymers, all while preserving their inherent bioactivity and functions. Although natural biopolymers like plant proteins and polysaccharides can replacecertain synthetic polymers, in most cases, there's a scarcity of high-performance biopolymers with properties like oil-soluble, water-resistant, flexible, strength, etc and options that meet the required specifications are rare. Few candidates derived from bio-based monomers or chemical processes using natural small molecules fulfil these criteria, but their production often compromises bioactivity and biodegradability.In traditional chemistry, functionalizing biomacromolecules into useful biopolymers has been a complex challenge, often leading to low yields and high costs when balancing performance and bioactivity. However, Greenitio's innovative technology overcomes these hurdles by implementing a biogenic process. This groundbreaking approach converts low-value, underperforming biomacromolecules into high-value, high-performance functional biopolymers sustainably and affordably—previously deemed unattainable.Remarkably, Greenitio's methodology not only preserves but enhances the natural bioactivity of biomacromolecules, unlocking the boundless potential for innovation and possibilities. Our biopolymers offer superior bioactivity and health benefits that surpass synthetic alternatives. Competing technologies only prioritize performance. We proudly offer a rare combination of performance and bioactivity at an affordable price. | $1.5M / Seed / Sep 02, 2025 | ||
| Enabling the transition to 2.5D and 3D chiplet stacking and increasing the performance of semiconductor chips to meet the growing demand. | $5.7M / Seed / Aug 12, 2025 | ||
| Allay Therapeutics offers analgesic products for post-surgical pain management and recuperation. The company was founded in 2017 and is headquartered in Menlo Park, California, United States. | $57.5M / Series D / Jun 05, 2025 | ||
| See all 107 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does SGInnovate invest in?
SGInnovate invests primarily in Artificial Intelligence, Software and Information Technology startups, most often at Seed and Series A stage. Most of the 107 investments tracked by Shizune back companies in Singapore. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is SGInnovate's check size?
SGInnovate typically joins rounds of $612k–$5M at Seed and $2M–$18M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds SGInnovate participates in.
How do I contact SGInnovate?
Public channels for SGInnovate include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at SGInnovate?
The team at SGInnovate includes Hsien Hui Tong (Executive Director - Investments), Jui Lim (Chief Executive Officer) and Pang Heng Soon (Chief Operating Officer). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
